Leuk Lymphoma 2019 06 10;60(6):1370-1380. Epub 2019 Jan 10.
a Department of Hematology , West China Hospital, Sichuan University , Chengdu , China.
Acute myeloid leukemia (AML) is the most common tumor in adult patients, most of the patients have a poor prognosis even after high-intensity chemotherapy, especially for relapsed, refractory or elderly patients. Therefore, new methods are needed to change the outcomes. In recent years, an increasing number of immune-therapies are emerging where adoptive cell therapy, a special immunotherapy, has become a promising strategy for AML. Read More